Pardes Biosciences, Inc.
Pardes Biosciences, Inc. (PRDS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PRDS · as of Jun 9, 2026
Key Statistics
Explore Pardes Biosciences, Inc. Data
prds stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 33.3%
Competitors & Peers
prds competitorsPRDS
ATYR
DBTX
GRAY
HLVX
KNTEStock Performance
Full HistoryAbout Pardes Biosciences, Inc.
Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated to identifying, developing, and marketing groundbreaking treatments. The company's core objective is to improve outcomes f…
what is pardes biosciences, inc. · prds stock overview · pardes biosciences, inc. company profile · who is pardes biosciences, inc. ceo · prds NASDAQ · pardes biosciences, inc. headquarters · pardes biosciences, inc. business segments
About Stock Overview & Key Data
Pardes Biosciences, Inc. (PRDS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 27, 2021. As of the latest trading session, PRDS stock price is $2.18, with a market capitalization of $135.2M. The stock has returned +9.55% over the past 12 months and +20.44% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Pardes Biosciences, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2022, Pardes Biosciences, Inc. reported revenue of — and net income of -$93.5M. For detailed data — including Pardes Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Pardes Biosciences, Inc. (PRDS) stock price is $2.18. The stock is traded on NASDAQ under the ticker symbol PRDS. The 52-week range is $0.75 – $3.67.